Open AccessPhase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer
Author(s) -
Jonathan D Sorah,
Dominic T. Moore,
Matthew J. Reilley,
Mohamed E. Salem,
Tammy Triglianos,
Hanna K. Sanoff,
Autumn J. McRee,
Michael S. Lee
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac222
Subject(s) - medicine , cetuximab , palbociclib , kras , oncology , neuroblastoma ras viral oncogene homolog , colorectal cancer , clinical endpoint , cancer , panitumumab , lapatinib , clinical trial , metastatic breast cancer , breast cancer , trastuzumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom